Meeting
2014 Genitourinary Cancers Symposium
Treatment pattern and prognosis in Japanese patients with metastatic renal cell carcinoma (mRCC) with favorable or intermediate MSKCC risk factors in the era of molecular targeted therapy.
Authors
Nobuo Shinohara
Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Nobuo Shinohara , Satoru Maruyama , Wataru Obara , Katsunori Tatsugami , Sei Naito , Tomomi Kamba , Seiji Naito
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 532)
DOI
10.1200/jco.2014.32.4_suppl.532
Abstract #
532
Poster Bd #
J7
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Risk factors and a model to predict toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: Results from the International Metastatic RCC Database Consortium.
First Author: Marina Dusevic Kaymakcalan
Poster
2015 Genitourinary Cancers Symposium
Prognostic biomarker exploration for patients with metastatic renal cell carcinoma receiving VEGFR TKI.
First Author: Inkeun Park
Poster
2014 Genitourinary Cancers Symposium
Heterogeneity of intermediate prognosis patients (pts) with metastatic renal cell cancer (mRCC) treated with sunitinib.
First Author: Avishay Sella
Poster
2012 Genitourinary Cancers Symposium
Tumor burden as an independent prognostic factor in metastatic renal cell carcinoma (mRCC).
First Author: Bernard J. Escudier